The BRAVE Coalition Foundation has received a significant charitable contribution from Johnson & Johnson, reinforcing a partnership dedicated to supporting breast cancer survivors and advancing patient-centered education about reconstruction options. This donation continues the company's support for the coalition, which began in 2018, and reflects a shared commitment to empowering women with knowledge and resources throughout their recovery journey.
Johnson & Johnson's ongoing financial support directly advances the BRAVE Coalition's core mission of advocacy, education, and ensuring equitable access to care. The foundation works to ensure women have the necessary support to make informed decisions about their bodies following a breast cancer diagnosis. "Support like this allows us to expand our reach and deepen our impact," stated Lisa Shumpert, President of the BRAVE Coalition Foundation. She emphasized that the investment highlights the importance of supporting patients not only during treatment but throughout the entire reconstruction and healing process.
The coalition's initiatives, which will be bolstered by this contribution, include comprehensive patient education programs, collaboration with surgeons, extensive community outreach, and the development of survivor resources. A primary organizational goal is to remove barriers to care and elevate awareness about the full spectrum of breast reconstruction options, aiming to make these choices accessible regardless of a patient's insurance coverage or socioeconomic status. The BRAVE Coalition Foundation, founded in 2012 by Dr. Allen Gabriel and Dr. Christine Grogan, is the first 501(c)(3) not-for-profit charitable foundation of its kind dedicated to this specific cause. The organization operates on the principle that every woman has the right to decide how to shape her recovery from breast cancer.
This latest infusion of support will enable the foundation to further its advocacy for informed choice, access, and empowerment for breast cancer survivors across the country. The impact of such sustained philanthropic partnerships extends beyond immediate funding; it validates the critical need for patient advocacy in post-cancer care and helps normalize conversations about reconstruction as a standard part of holistic recovery. For individuals seeking more information about the foundation's work, resources are available at https://www.bravecoalition.org.
